A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study from researchers at Weill Cornell Medicine.
Spring 1Q EIPM Director's Memo
April 11, 2022
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our first quarterly newsletter of 2022!
April 2022 EIPM Director's Memo
April 1, 2022
Dear Members of the Englander Institute,
March was another very busy month for us, with important awards and honors for Drs. Anandasabapathy, Ocean, Faltas and Hajirasouliha, well done! We also generated a lot of news media coverage, participated in important events, and published impactful research.
We celebrated International Women’s Day on March 8th by paying tribute on our social media channels to some of the women who motivate and inspire us.
Specialized Liver Blood Vessel Identity Factor Required for Regeneration
March 31, 2022
Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.
Novel Technique Provides Insights into Lung Pathology in COVID-19
March 11, 2022
Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases. In the study, published in the May 2021 issue of Nature, the researchers imaged autopsied lung tissue in a way that simultaneously highlighted dozens of molecular markers on cells.
EIPM Researcher Wins Starr Cancer Consortium Funding
March 10, 2022
Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.
The Next Life-Saving Innovation Developed Only for You
March 7, 2022
When most people think of making technology more personalized, they imagine chatbots, or artificial intelligence programmed to speak in a human voice that turns search-engine output into small talk.
At Weill Cornell Medicine in New York City, personalized technology can mean the ability to map a patient’s entire genetic code in the time it takes to watch a movie, or tracking flecks of DNA in the blood to assess if a disease treatment is working.
EIPM’s Dr. Bishoy M. Faltas Wins 2022 Science Award ASCI Young Physician-Scientist Awards
March 3, 2022
Three Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation. The 2022 award recipients are Drs. Bishoy M. Faltas, Gunisha Kaur and Hasina Outtz Reed.
March 2022 EIPM Director's Memo
March 3, 2022
Dear Members of the Englander Institute,
February was a busy month for many of our colleagues who participated in live and virtual events (see below). By sharing their expertise across a wide range of topics, these events help attract attention to the EIPM and raise our profile as we continue to grow and recruit new talent. Thank you for taking the time out of your busy schedules to participate in these panels and conferences.
February 2022 EIPM Director's Memo
February 1, 2022
Dear Members of the Englander Institute,
I hope this message finds you doing well and staying healthy! It’s hard to believe that January is already behind us, but as you’ll see below, we have a lot to show for the first month of 2022.
In addition to robust news coverage, awards, events, and publications, we welcome three new senior members of our team. Drs. Cristofanilli, Kasi, and Al Assaad bring a wealth of experience and talent to the EIPM.
